JP2014504858A - 体重減少および維持のためのペットフード組成物および方法 - Google Patents
体重減少および維持のためのペットフード組成物および方法 Download PDFInfo
- Publication number
- JP2014504858A JP2014504858A JP2013546162A JP2013546162A JP2014504858A JP 2014504858 A JP2014504858 A JP 2014504858A JP 2013546162 A JP2013546162 A JP 2013546162A JP 2013546162 A JP2013546162 A JP 2013546162A JP 2014504858 A JP2014504858 A JP 2014504858A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- animal
- amount
- pet food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 235000013305 food Nutrition 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000004580 weight loss Effects 0.000 title claims description 23
- 238000012423 maintenance Methods 0.000 title claims description 12
- 241001465754 Metazoa Species 0.000 claims abstract description 91
- 208000008589 Obesity Diseases 0.000 claims abstract description 20
- 235000020824 obesity Nutrition 0.000 claims abstract description 20
- 235000019197 fats Nutrition 0.000 claims description 23
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 18
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 17
- 241000282465 Canis Species 0.000 claims description 17
- 235000021360 Myristic acid Nutrition 0.000 claims description 17
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 17
- 239000011648 beta-carotene Substances 0.000 claims description 17
- 235000013734 beta-carotene Nutrition 0.000 claims description 17
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 17
- 229960002747 betacarotene Drugs 0.000 claims description 17
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 17
- 241000282324 Felis Species 0.000 claims description 16
- 238000011282 treatment Methods 0.000 claims description 14
- 235000013325 dietary fiber Nutrition 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 9
- 244000000626 Daucus carota Species 0.000 claims description 8
- 235000002767 Daucus carota Nutrition 0.000 claims description 8
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 8
- 210000003205 muscle Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 102000016267 Leptin Human genes 0.000 claims description 7
- 108010092277 Leptin Proteins 0.000 claims description 7
- 239000003240 coconut oil Substances 0.000 claims description 7
- 235000019864 coconut oil Nutrition 0.000 claims description 7
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims description 7
- 229940039781 leptin Drugs 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 5
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims description 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241000227653 Lycopersicon Species 0.000 claims 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 239000005639 Lauric acid Substances 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 229960004203 carnitine Drugs 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 1
- 235000020778 linoleic acid Nutrition 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 description 18
- 241000282472 Canis lupus familiaris Species 0.000 description 17
- 241000282326 Felis catus Species 0.000 description 15
- 230000037396 body weight Effects 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 11
- 206010033307 Overweight Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 240000003768 Solanum lycopersicum Species 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 5
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 230000003442 weekly effect Effects 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 238000002705 metabolomic analysis Methods 0.000 description 2
- 230000001431 metabolomic effect Effects 0.000 description 2
- 238000011328 necessary treatment Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 231100000272 reduced body weight Toxicity 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000020354 squash Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 235000021411 American diet Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- -1 coconut oil Chemical compound 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/48—Moist feed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
好ましい実施形態の以下の説明は、事実上は単なる例示であり、本発明、その応用または用途を限定することを意図するものではない。
実施例
動物組成物は以下の通り調製された:各フードは、ネコまたはイヌのための、米国飼料検査官協会栄養素ガイド(Association of American Feed Control Officials nutrient guide)に従って粗くひかれ(kibbled)、配合された(formulated)、成体の維持要求量(maintenance requirements)に合うようにバランスを取られた。動物は、動物実験委員会(Institutional Animal Care and Use Committee)のプロトコルに従って監督された。
40匹のネコが4ヶ月間の体重減少試験に採用され、2つの処置群、それぞれ20匹ずつのネコに分けられ、配合FAまたは配合FBのいずれかが与えられた。全てのネコは、総体重の31.6%を超える体脂肪で、本試験を開始した。ネコは、4ヶ月の間、または適正体重、すなわち20%の体脂肪、が達成されるまで、体重減少試験を続けた。
40匹のイヌが4ヶ月間の体重減少試験に採用され、2つの処置群、それぞれ20匹ずつのイヌに分けられ、配合CAまたは配合CBのいずれかが与えられた。全てのイヌは、総体重の33.1%を超える体脂肪で、本試験を開始した。イヌは、4ヶ月の間、または適正体重、すなわち20%の体脂肪、が達成されるまで、体重減少試験を続けた。
Claims (21)
- ミリスチン酸源およびベータ−カロテン源を、コンパニオンアニマルにおける肥満を予防または治療するのに有効な量で含む、ペットフード組成物。
- ミリスチン酸源が少なくとも0.3%の量である、請求項1に記載の組成物。
- ベータ−カロテン源が少なくとも2ppmの量である、請求項1または請求項2に記載の組成物。
- 該ミリスチン酸源がヤシ油を含み、該ベータ−カロテン源がトマトの搾りかすおよびニンジン粉末の少なくとも1つを含む、前記請求項のいずれかに記載の組成物。
- トマトの搾りかすの量が約2重量%から約8重量%であり;ヤシ油の量が約0.5重量%から約6.0重量%であり;かつニンジン粉末の量が約0.1重量%から約2.0重量%である、請求項4に記載の組成物。
- 約20重量%から約50重量%の総タンパク質;
約15重量%から約50重量%の総食物繊維;および
約3重量%から約15重量%の脂肪、
を含む、前記請求項のいずれかに記載の組成物。 - リポ酸をさらに含む、前記請求項のいずれかに記載の組成物。
- コンパニオンアニマルが、イヌ科の動物またはネコ科の動物である、前記請求項のいずれかに記載の組成物。
- 請求項1〜7のいずれか1項に記載の組成物を、肥満の予防または治療が必要なコンパニオンアニマルに与えることを含む、コンパニオンアニマルにおける肥満を予防または治療するための方法。
- 前記給餌が、除脂肪筋肉量の付随する減少なしに肥満を予防または治療する、請求項9に記載の方法。
- 組成物が少なくとも1日に1回動物に与えられる、請求項9に記載の方法。
- 組成物が、動物がその正常体重範囲に達するまで、少なくとも1日に1回動物に与えられる、請求項9に記載の方法。
- 組成物の少なくとも1日に1回の動物への給餌が、動物がその正常体重範囲に達した後も続けられ、それによって動物がその正常体重を維持する、請求項12に記載の方法。
- 組成物が、少なくとも一週間、少なくとも1日に1回与えられる、請求項9に記載の方法。
- 組成物が、少なくとも一ヶ月間、少なくとも1日に1回与えられる、請求項9に記載の方法。
- 組成物が、少なくとも二ヶ月間、少なくとも1日に1回与えられる、請求項9に記載の方法。
- 該給餌が、動物におけるレプチンおよびインスリン様成長因子−1(IGF−1)の血清レベルを減少させる、請求項9〜16のいずれか1項に記載の方法。
- コンパニオンアニマルが、イヌ科の動物またはネコ科の動物である、請求項9〜16のいずれか1項に記載の組成物。
- コンパニオンアニマルのための、体重減少および維持ペットフード組成物の製造のためのミリスチン酸源およびベータ−カロテン源の使用。
- 1から4重量%のアルギニン;0.01から1.5重量%のシステイン;0.01から1.5重量%のヒスチジン;0.1から3重量%のイソロイシン;2から6重量%のロイシン;0.1から4重量%のリジン;0.1から3重量%のメチオニン;0.1から4重量%のフェニルアラニン;0.1から3重量%のトレオニン;0.01から2重量%のトリプトファン;0.1から4重量%のチロシン;および0.5から4重量%のバリンを含む、20から50重量%のタンパク質;
0.05から3重量%のラウリン酸;0.01から1.5重量%のミリスチン酸;および0.1から6重量%のリノール酸を含む、8から13重量%の脂肪;
15から30重量%の不溶性繊維および1から10重量%の可溶性繊維を含む、15から50重量%の食物繊維;
0.1から2重量%のカルシウム;0.01から2重量%の塩化物;0.001から1.5重量%のマグネシウム;0.01から1.5重量%のリン;0.01から1.5重量%のカリウム;0.01から1.5重量%のナトリウム;および200から750mg/kgのカルニチン、
を含む、ペットフード組成物。 - 20から150ppmのリポ酸をさらに含む、請求項20に記載のペットフード組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061426629P | 2010-12-23 | 2010-12-23 | |
US61/426,629 | 2010-12-23 | ||
PCT/US2011/062526 WO2012087511A1 (en) | 2010-12-23 | 2011-11-30 | Pet food compositions and methods for weight loss and maintenance |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014504858A true JP2014504858A (ja) | 2014-02-27 |
JP6029593B2 JP6029593B2 (ja) | 2016-11-24 |
Family
ID=45390180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013546162A Active JP6029593B2 (ja) | 2010-12-23 | 2011-11-30 | 体重減少および維持のためのペットフード組成物および方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9168240B2 (ja) |
EP (1) | EP2654453B1 (ja) |
JP (1) | JP6029593B2 (ja) |
CN (2) | CN103260425A (ja) |
AU (1) | AU2011345225B2 (ja) |
BR (1) | BR112013016217A2 (ja) |
CA (1) | CA2822334C (ja) |
DK (1) | DK2654453T3 (ja) |
ES (1) | ES2589180T3 (ja) |
RU (1) | RU2553650C2 (ja) |
WO (1) | WO2012087511A1 (ja) |
ZA (1) | ZA201304293B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018188381A (ja) * | 2017-04-28 | 2018-11-29 | 国立大学法人千葉大学 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
WO2022176677A1 (ja) * | 2021-02-19 | 2022-08-25 | 株式会社J-オイルミルズ | 筋肉増強用組成物及びその利用 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2538388C1 (ru) | 2010-12-23 | 2015-01-10 | Хилл'С Пет Ньютришн, Инк. | Кормовые композиции для домашних животных и способы лечения артрита и воспалений, связанных с артритом |
WO2014092717A1 (en) * | 2012-12-14 | 2014-06-19 | Hill's Pet Nutrition, Inc. | Anti-aging foods for companion animals |
WO2016113387A1 (en) | 2015-01-15 | 2016-07-21 | Dsm Ip Assets B.V. | Combination of 25-hydroxyvitamin d and antioxidants/anti-inflammatories for human nutraceuticals |
JP6623417B2 (ja) * | 2015-01-15 | 2019-12-25 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | 家禽の卵巣の健康のための25−ヒドロキシビタミンdと酸化防止剤/抗炎症剤との組み合わせ |
WO2016130981A1 (en) * | 2015-02-13 | 2016-08-18 | Mars, Incorporated | Pet food feeding system |
GB201522304D0 (en) | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
CN105746908B (zh) * | 2016-02-23 | 2018-08-28 | 广州英赛特生物技术有限公司 | 肉豆蔻酸衍生物在制备动物生长促进剂中的应用 |
JP2019528698A (ja) * | 2016-09-02 | 2019-10-17 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | イヌ科動物において胃腸管微生物叢を調節するための組成物及び方法 |
CN109999019B (zh) * | 2018-01-04 | 2021-11-16 | 中国科学院动物研究所 | 肉豆蔻脑酸甲酯在制备预防或治疗代谢综合征或改善机体能量代谢的产品中的应用 |
BR112021015145A2 (pt) * | 2019-02-01 | 2021-09-28 | Mars, Incorporated | Composição alimentar felina |
JP6753997B1 (ja) * | 2019-12-17 | 2020-09-09 | ユニ・チャーム株式会社 | ペットの体重管理方法 |
EP4199736A1 (en) * | 2020-10-14 | 2023-06-28 | Hill's Pet Nutrition, Inc. | Pet food compositions |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005522230A (ja) * | 2002-04-15 | 2005-07-28 | マーズ インコーポレイテッド | 食品の栄養含量を高めるための組成物 |
WO2009046964A1 (en) * | 2007-10-10 | 2009-04-16 | Dsm Ip Assets B.V. | Feed composition for companion animals |
WO2010078301A1 (en) * | 2008-12-30 | 2010-07-08 | Hill's Pet Nutrition, Inc. | Compositions and methods for treating and preventing weight-related disorders in companion animals |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1368784A (en) | 1970-12-09 | 1974-10-02 | Astra Nutrition Ab | Foodstuffs for young animals |
US6133323A (en) | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
US6403142B1 (en) | 1998-12-11 | 2002-06-11 | Ralston Purina Company | Hypoallergenic pet food |
US6669975B1 (en) | 2000-02-03 | 2003-12-30 | Mars Incorporated | Customized dietary health maintenance system for pets |
AU784087B2 (en) * | 2000-06-09 | 2006-02-02 | Megmilk Snow Brand Co., Ltd. | Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof |
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US8669282B2 (en) | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
EP1446023B1 (en) | 2001-11-12 | 2009-02-25 | Mars, Incorporated | Foodstuff for cats and dogs |
CN1215778C (zh) * | 2003-04-21 | 2005-08-24 | 赵日万 | 宠物饲料及其制法 |
CA2533590C (en) * | 2003-09-05 | 2013-03-12 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
US8715717B2 (en) | 2003-09-05 | 2014-05-06 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
US20050176674A1 (en) | 2004-02-09 | 2005-08-11 | Friesen Kim G. | Composition and method for use in cartilage affecting conditions |
US8377904B2 (en) | 2004-02-09 | 2013-02-19 | Hill's Pet Nutrition, Inc. | Composition and method for use in cartilage affecting conditions |
US20100233312A9 (en) | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
US20060228448A1 (en) | 2005-04-11 | 2006-10-12 | The Iams Company | Pet food compositions comprising two components |
CA2678808C (en) * | 2007-02-23 | 2012-07-10 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating obesity in animals |
US20080233244A1 (en) | 2007-03-23 | 2008-09-25 | Solae, Llc | Animal food compositions and treats |
US20080233248A1 (en) | 2007-03-23 | 2008-09-25 | Vetscience Llc | Animal Feed with Targeted Characteristics |
CA2767910C (en) | 2009-07-21 | 2014-07-08 | Hill's Pet Nutrition, Inc. | Companion animal nutrition system |
RU2551965C2 (ru) | 2010-12-20 | 2015-06-10 | Хилл'С Пет Ньютришн, Инк. | Кормовые композиции для домашних животных, вызывающие чувство сытости |
RU2538388C1 (ru) | 2010-12-23 | 2015-01-10 | Хилл'С Пет Ньютришн, Инк. | Кормовые композиции для домашних животных и способы лечения артрита и воспалений, связанных с артритом |
-
2011
- 2011-11-30 AU AU2011345225A patent/AU2011345225B2/en active Active
- 2011-11-30 US US13/997,353 patent/US9168240B2/en active Active
- 2011-11-30 CA CA2822334A patent/CA2822334C/en active Active
- 2011-11-30 EP EP11799538.1A patent/EP2654453B1/en not_active Revoked
- 2011-11-30 ES ES11799538.1T patent/ES2589180T3/es active Active
- 2011-11-30 CN CN2011800624071A patent/CN103260425A/zh active Pending
- 2011-11-30 RU RU2013134248/13A patent/RU2553650C2/ru not_active IP Right Cessation
- 2011-11-30 WO PCT/US2011/062526 patent/WO2012087511A1/en active Application Filing
- 2011-11-30 DK DK11799538.1T patent/DK2654453T3/da active
- 2011-11-30 BR BR112013016217A patent/BR112013016217A2/pt not_active Application Discontinuation
- 2011-11-30 JP JP2013546162A patent/JP6029593B2/ja active Active
- 2011-11-30 CN CN201610146433.7A patent/CN105661079A/zh active Pending
-
2013
- 2013-06-11 ZA ZA2013/04293A patent/ZA201304293B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005522230A (ja) * | 2002-04-15 | 2005-07-28 | マーズ インコーポレイテッド | 食品の栄養含量を高めるための組成物 |
WO2009046964A1 (en) * | 2007-10-10 | 2009-04-16 | Dsm Ip Assets B.V. | Feed composition for companion animals |
WO2010078301A1 (en) * | 2008-12-30 | 2010-07-08 | Hill's Pet Nutrition, Inc. | Compositions and methods for treating and preventing weight-related disorders in companion animals |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018188381A (ja) * | 2017-04-28 | 2018-11-29 | 国立大学法人千葉大学 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
JP7044342B2 (ja) | 2017-04-28 | 2022-03-30 | 国立大学法人千葉大学 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
WO2022176677A1 (ja) * | 2021-02-19 | 2022-08-25 | 株式会社J-オイルミルズ | 筋肉増強用組成物及びその利用 |
Also Published As
Publication number | Publication date |
---|---|
BR112013016217A2 (pt) | 2018-05-15 |
EP2654453B1 (en) | 2016-06-01 |
JP6029593B2 (ja) | 2016-11-24 |
RU2013134248A (ru) | 2015-01-27 |
CN103260425A (zh) | 2013-08-21 |
AU2011345225B2 (en) | 2014-12-04 |
US20130281533A1 (en) | 2013-10-24 |
ES2589180T3 (es) | 2016-11-10 |
ZA201304293B (en) | 2016-08-31 |
US9168240B2 (en) | 2015-10-27 |
DK2654453T3 (da) | 2016-08-29 |
CN105661079A (zh) | 2016-06-15 |
AU2011345225A1 (en) | 2013-05-09 |
CA2822334A1 (en) | 2012-06-28 |
CA2822334C (en) | 2016-07-05 |
RU2553650C2 (ru) | 2015-06-20 |
WO2012087511A1 (en) | 2012-06-28 |
EP2654453A1 (en) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6029593B2 (ja) | 体重減少および維持のためのペットフード組成物および方法 | |
US10327459B2 (en) | Compositions and methods for controlling the weight of animals | |
AU2010336986B2 (en) | Compositions including pyruvate for companion animals and methods of use thereof | |
JP5081236B2 (ja) | 甲状腺機能亢進症のネコ科動物において心臓血管系疾患を予防又は治療するための組成物及び方法 | |
RU2426443C2 (ru) | Композиции и способы контроля массы животного (варианты) | |
AU2007347423A1 (en) | Compositions and methods for preventing or treating obesity in animals | |
JP6027978B2 (ja) | 関節炎および関節炎に関連する炎症を治療するためのペットフード組成物および方法 | |
WO2009008885A1 (en) | Cholesterol reducing food compositions for animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20140303 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140325 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140826 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140829 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141125 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20141202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141224 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150804 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151015 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20151104 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20160115 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20160411 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160418 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161018 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6029593 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |